Search

everythinglearnresearchcommunity

for

Search:↓

The 39th Manfred Donike Workshop discussed methods for detecting misuse of steroids, gene doping, and the complexity of identifying drug residues in urine, highlighting the ongoing efforts to improve global anti-doping work.

High prolactin and low vitamin D levels may be linked to hair loss in women.

Low levels of vitamin B12, iron, ferritin, and zinc are linked to hair loss in Iraqi women.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Sex hormones and antiandrogens can either stimulate or inhibit human hair follicle cell growth depending on the dose.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

Men with early hair loss and certain health factors may have a higher risk of developing reproductive issues, similar to polycystic ovary syndrome in women.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

Hormonal imbalances are important in the development of male pattern baldness.

Women with schizophrenia on atypical antipsychotics are more likely to have polycystic ovarian syndrome (PCOS) than women without schizophrenia.

Lean and obese women with PCOS have similar levels of insulin resistance, indicating it's a core aspect of the condition.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Dutasteride does not seem to change rat spermatogenesis or oxidative stress.

Dutasteride did not change rat spermatogenesis or oxidative stress but needs more research.

PCOS patients with autoimmune thyroid disease have lower DHEAS levels.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Activin helps skin growth and healing mainly through stromal cells and affects keratinocytes based on its amount.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.